Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunisation Stress-related Responses with COVID-19 mRNA Vaccine

View ORCID ProfileKazuo Imai, Fumika Tanaka, Shuichi Kawano, Kotoba Esaki, Junko Arakawa, Takashi Nishiyama, Soichiro Seno, Kosuke Hatanaka, Takao Sugiura, Yu Kodama, Seigo Yamada, Shinichiro Iwamoto, Shigeto Takesima, Nobujiro Abe, Chikako Kamae, Shigeaki Aono, Toshimitsu Ito, Tetsuo Yamamoto, Yasunori Mizuguchi
doi: https://doi.org/10.1101/2022.01.12.22269134
Kazuo Imai
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
2Self-Defense Forces Central Hospital, Department of Internal Medicine, Tokyo, Japan
3Japan Ground Self-Defense Force, NBC Countermeasure Medical Unit, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kazuo Imai
  • For correspondence: k_imai@saitama-med.ac.jp
Fumika Tanaka
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuichi Kawano
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
2Self-Defense Forces Central Hospital, Department of Internal Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kotoba Esaki
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
2Self-Defense Forces Central Hospital, Department of Internal Medicine, Tokyo, Japan
3Japan Ground Self-Defense Force, NBC Countermeasure Medical Unit, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junko Arakawa
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
2Self-Defense Forces Central Hospital, Department of Internal Medicine, Tokyo, Japan
3Japan Ground Self-Defense Force, NBC Countermeasure Medical Unit, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Nishiyama
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soichiro Seno
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kosuke Hatanaka
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takao Sugiura
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu Kodama
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seigo Yamada
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinichiro Iwamoto
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeto Takesima
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
4Self-Defense Forces Central Hospital, Department of Emergency Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobujiro Abe
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
2Self-Defense Forces Central Hospital, Department of Internal Medicine, Tokyo, Japan
3Japan Ground Self-Defense Force, NBC Countermeasure Medical Unit, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chikako Kamae
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
5Japan Ground Self-Defense Force, Eastern Army Medical Unit, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeaki Aono
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
2Self-Defense Forces Central Hospital, Department of Internal Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshimitsu Ito
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
2Self-Defense Forces Central Hospital, Department of Internal Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuo Yamamoto
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
3Japan Ground Self-Defense Force, NBC Countermeasure Medical Unit, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasunori Mizuguchi
1Self-Defense Forces Tokyo Large-scale Vaccination Centre, Tokyo, Japan
6Self-Defense Forces Central Hospital, Department of Urology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background With the implementation of mass vaccination campaigns against COVID-19, the safety of vaccine needs to be evaluated.

Objective We aimed to assess the incidence and risk factors for immediate hypersensitivity reactions (IHSR) and immunisation stress-related responses (ISRR) with the Moderna COVID-19 vaccine.

Methods This nested case-control study included recipients who received the Moderna vaccine at a mass vaccination centre, Japan. Recipients with IHSR and ISRR were designated as cases 1 and 2, respectively. Controls 1 and 2 were selected from recipients without IHSR or ISRR and matched (1:4) with cases 1 and cases 2, respectively. Conditional logistic regression analysis was used to identify risk factors associated with IHSR and ISRR.

Results Of the 614,151 vaccine recipients who received 1,201,688 vaccine doses, 306 recipients (cases 1) and 2,478 recipients (cases 2) showed 318 events of IHSR and 2,558 events of ISRR, respectively. The incidence rates per million doses were estimated as – IHSR: 266 cases, ISRR: 2,129 cases, anaphylaxis: 2 cases, and vasovagal syncope: 72 cases. Risk factors associated with IHSR included female, asthma, atopic dermatitis, thyroid diseases, and history of allergy; for ISRR, they were younger age, female, asthma, thyroid diseases, mental disorders, and a history of allergy and vasovagal reflex.

Conclusion In the mass vaccination settings, the Moderna vaccine can be used safely owing to the low incidence rates of IHSR and anaphylaxis. However, providers should beware of the occurrence of ISRR. Risk factor identification may contribute to the stratification of high-risk recipients for IHSR and ISRR.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research did not receive any specific grant from funding agencies in the public, commercial, or nonprofit sectors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of Self-Defence Forces Central Hospital gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict-of-interest statement The authors have nothing to disclose.

Data Availability

The datasets analysed during the current study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 13, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunisation Stress-related Responses with COVID-19 mRNA Vaccine
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunisation Stress-related Responses with COVID-19 mRNA Vaccine
Kazuo Imai, Fumika Tanaka, Shuichi Kawano, Kotoba Esaki, Junko Arakawa, Takashi Nishiyama, Soichiro Seno, Kosuke Hatanaka, Takao Sugiura, Yu Kodama, Seigo Yamada, Shinichiro Iwamoto, Shigeto Takesima, Nobujiro Abe, Chikako Kamae, Shigeaki Aono, Toshimitsu Ito, Tetsuo Yamamoto, Yasunori Mizuguchi
medRxiv 2022.01.12.22269134; doi: https://doi.org/10.1101/2022.01.12.22269134
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunisation Stress-related Responses with COVID-19 mRNA Vaccine
Kazuo Imai, Fumika Tanaka, Shuichi Kawano, Kotoba Esaki, Junko Arakawa, Takashi Nishiyama, Soichiro Seno, Kosuke Hatanaka, Takao Sugiura, Yu Kodama, Seigo Yamada, Shinichiro Iwamoto, Shigeto Takesima, Nobujiro Abe, Chikako Kamae, Shigeaki Aono, Toshimitsu Ito, Tetsuo Yamamoto, Yasunori Mizuguchi
medRxiv 2022.01.12.22269134; doi: https://doi.org/10.1101/2022.01.12.22269134

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (551)
  • Anesthesia (135)
  • Cardiovascular Medicine (1751)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10790)
  • Forensic Medicine (8)
  • Gastroenterology (585)
  • Genetic and Genomic Medicine (2938)
  • Geriatric Medicine (286)
  • Health Economics (532)
  • Health Informatics (1920)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (291)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12505)
  • Intensive Care and Critical Care Medicine (686)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2788)
  • Nursing (150)
  • Nutrition (432)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1459)
  • Ophthalmology (442)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2635)
  • Public and Global Health (5346)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (725)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)